JAMA (Yang, Y., et al. )10. 24. 2023 published an original investigation “Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.” Investigators of this clinical study conducted a randomized, double-blind, placebo-controlled clinical trial of 3777 patients with acute ST-segment elevation myocardial infarction (STEMI). Patients from 124 hospitals in China presenting with STEMI between May-December 2020 were given either oral Tongxinluo or placebo within 24 hours of symptom onset. The adjunctive treatment or placebo was administered for 12 months, and positive patient outcome was observed.
Free Webinar: Pregnancy & Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
You are invited to join Sarah Mulkey, M.D., Ph.D. to learn about a new study at Children’s National Hospital on the effects of Lyme disease on pregnancy and early neurodevelopmental outcomes. Held on Zoom, May 3rd – Free – 7PM
Columbia University Irving Medical Center’s Clinical Trials Network (CTN) for Lyme and Other Tick-Borne Diseases, established with a grant from the Steven & Alexandra Cohen Foundation to Columbia University, has announced the third round of Pilot Study Proposal submissions. Clinicians, researchers, and investigators from educational institutions are welcome to submit proposals.
Johns Hopkins Center for Psychedelic & Consciousness Research announced in its Summer 2022 Newsletter a new study opportunity. Patients suffering from Post-Treatment Lyme Disease in the Baltimore area who continue […]
The Lyme Disease Association, Inc. is posting the following announcement for the CTN to clinicians, researchers & investigators from academic institutions. We are happy to announce that the Clinical Trials […]
Columbia CTN Announces 2nd Call: Treatment Research Ideas from Public, Clinicians, Others: Invitation to Participate: The Columbia Clinical Trails Newtwork Coordinating Center (CTNCC) welcomes input from the public, community clinicians, and […]
Heidi K. Goethert, et al., published, “Incrimination of shrews as a reservoir for Powassan virus,” in Communications Biology. The study examines Powassan virus lineage 2 (deer tick virus), and the growing threat the pathogen poses to American public health. Powassan virus is known to cause severe neurologic disease although its life cycle in nature is poorly understood.
Deadline Aug. 1 The Lyme Disease Association Inc. is notifying researchers that the Clinical Trials Network established with a grant from the Steven & Alexandra Cohen Foundation to Columbia […]
From Columbia Clinical Trials Network: In recognition of a severe unmet need, the Steven and Alexandra Cohen Foundation’s grant to Columbia University has established the first national Columbia Clinical Trials […]